Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 21 studies | 48% ± 17% | |
peripheral blood | 21 studies | 63% ± 20% | |
brain | 19 studies | 39% ± 20% | |
intestine | 11 studies | 47% ± 18% | |
kidney | 10 studies | 39% ± 12% | |
eye | 10 studies | 55% ± 17% | |
liver | 7 studies | 44% ± 18% | |
bone marrow | 6 studies | 45% ± 27% | |
lymph node | 6 studies | 53% ± 20% | |
placenta | 5 studies | 43% ± 20% | |
heart | 5 studies | 31% ± 5% | |
uterus | 5 studies | 61% ± 22% | |
adipose | 5 studies | 40% ± 16% | |
prostate | 5 studies | 50% ± 16% | |
breast | 5 studies | 51% ± 13% | |
pancreas | 4 studies | 58% ± 13% | |
esophagus | 4 studies | 50% ± 25% | |
skin | 4 studies | 34% ± 11% | |
adrenal gland | 3 studies | 43% ± 19% | |
stomach | 3 studies | 41% ± 30% | |
thymus | 3 studies | 63% ± 29% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 36832.67 | 245 / 245 | 100% | 168.41 | 502 / 502 |
stomach | 100% | 23048.25 | 359 / 359 | 100% | 67.30 | 286 / 286 |
uterus | 100% | 40502.59 | 170 / 170 | 100% | 113.67 | 459 / 459 |
thymus | 100% | 49748.31 | 653 / 653 | 100% | 165.63 | 604 / 605 |
lung | 100% | 29727.80 | 577 / 578 | 100% | 92.22 | 1155 / 1155 |
breast | 100% | 37179.12 | 459 / 459 | 100% | 115.66 | 1116 / 1118 |
intestine | 100% | 32476.21 | 966 / 966 | 100% | 79.54 | 526 / 527 |
bladder | 100% | 26438.14 | 21 / 21 | 100% | 102.37 | 503 / 504 |
skin | 100% | 30238.43 | 1809 / 1809 | 100% | 93.59 | 471 / 472 |
adrenal gland | 100% | 26285.61 | 258 / 258 | 100% | 111.56 | 229 / 230 |
liver | 100% | 15861.45 | 226 / 226 | 100% | 66.60 | 404 / 406 |
esophagus | 100% | 30673.79 | 1445 / 1445 | 99% | 66.95 | 182 / 183 |
kidney | 100% | 27210.60 | 89 / 89 | 99% | 99.54 | 896 / 901 |
pancreas | 99% | 12854.23 | 326 / 328 | 100% | 114.02 | 178 / 178 |
ovary | 100% | 45390.92 | 180 / 180 | 99% | 75.24 | 427 / 430 |
brain | 97% | 19925.92 | 2569 / 2642 | 100% | 133.01 | 705 / 705 |
adipose | 100% | 31429.99 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 134.65 | 29 / 29 |
spleen | 100% | 42445.37 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 97.03 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 165.08 | 1 / 1 |
blood vessel | 100% | 29399.38 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 16383.81 | 847 / 861 | 0% | 0 | 0 / 0 |
muscle | 98% | 13303.65 | 787 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 87.22 | 78 / 80 |
peripheral blood | 75% | 9408.94 | 695 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0006376 | Biological process | mRNA splice site recognition |
GO_0006397 | Biological process | mRNA processing |
GO_0016607 | Cellular component | nuclear speck |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | SRSF5 |
Protein name | Serine/arginine-rich splicing factor 5 (Delayed-early protein HRS) (Pre-mRNA-splicing factor SRP40) (Splicing factor, arginine/serine-rich 5) Serine and arginine rich splicing factor 5 (cDNA FLJ57437, highly similar to Splicing factor, arginine/serine-rich 5) Serine and arginine rich splicing factor 5 (cDNA FLJ57379, highly similar to Splicing factor, arginine/serine-rich 5) Serine and arginine rich splicing factor 5 Alternative protein SRSF5 |
Synonyms | SRP40 HRS SFRS5 |
Description | FUNCTION: Plays a role in constitutive splicing and can modulate the selection of alternative splice sites. |
Accessions | ENST00000555547.5 ENST00000553548.5 L8E9M6 ENST00000553369.5 Q13243 B4DJK0 ENST00000554021.1 B4DUA4 ENST00000394366.6 [Q13243-1] G3V5K8 ENST00000557154.6 [Q13243-1] ENST00000555349.5 ENST00000553635.5 [Q13243-3] ENST00000553521.5 [Q13243-1] |